Uso del producto: Este producto está destinado exclusivamente a la investigación.
Toda la información de los productos de este sitio web tiene fines exclusivamente educativos. Cualquier forma de introducción en el cuerpo de personas o animales está estrictamente prohibida por la ley. Este producto solo debe ser manipulado por profesionales autorizados y cualificados. No es un medicamento, alimento ni cosmético y no debe etiquetarse, utilizarse ni presentarse como tal.
GHRP-2 5mg
Durante el cambio de envase, puedes recibir productos con la etiqueta anterior o con la nueva. La formulación, la pureza y la calidad siguen siendo exactamente las mismas, según nuestros estándares.
- Tarjeta de crédito
- Transferencia bancaria (SEPA inmediata)
- Transferencia bancaria (ACH)
- Wise
- Revolut
- Zelle
- Remitly
- Western Union
- Chime
- Otros
-25% en todo – hasta el 31 de octubre
25% sobre los precios habituales, en sustitución de otras ofertas. Acumulable solo con el descuento crypto.
Envío en el día para pedidos en EE. UU. realizados antes de las 12:00 EST.
Ver la política de envíos →Devoluciones sin complicaciones en 30 días para productos sin abrir.
Ver la política de devoluciones →Cada lote se analiza para comprobar su pureza, potencia y calidad.
Ver resultados de laboratorio →GHRP-2 (Pralmorelin) is a synthetic hexapeptide compound studied for selective ghrelin receptor binding properties and growth hormone secretagogue signalling in experimental models.
The compound consists of six amino acids (D-Ala-D-β-Nal-Ala-Trp-D-Phe-Lys-NH2) and is examined for its capacity to engage the GHS-R1a (growth hormone secretagogue receptor 1a) in pituitary and hypothalamic research models. Research applications include ghrelin receptor pharmacology, growth hormone secretagogue pathway studies, and pulsatile GH signalling research.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
3D Molecular Structure
Drag to rotate · scroll to zoom| Chemical Formula | C45H55N9O6 |
|---|---|
| Synonyms | Pralmorelin, KP-102, D-Alanyl-3-(2-naphthalenyl)-D-alanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide, UNII-E6S6E1F19M |
| Molar Mass | 817.9865 g/mol |
| CAS Number | 158861-67-7 |
| PubChem CID | 6918245 |
| Total Compound Content | 5mg per vial |
| Shelf Life | 36 months |
Every batch is independently lab tested for identity, purity and potency. View our lab testing program →
What receptor does GHRP-2 bind to and how is this studied in laboratory models?
GHRP-2 is studied for selective agonist activity at the GHS-R1a (growth hormone secretagogue receptor 1a), which is expressed in pituitary somatotroph cells and hypothalamic nuclei. Cell-based binding assays using GHS-R1a-expressing cell lines, alongside downstream signalling readouts (such as cAMP accumulation and calcium mobilization), are standard methods for characterising GHRP-2's receptor engagement and functional potency relative to other GHS-R1a ligands.
What distinguishes GHRP-2's proposed mechanism from GHRH-based research tools?
GHRP-2 engages the ghrelin/GHS-R1a receptor pathway, distinct from the GHRH receptor pathway targeted by GHRH analogues such as CJC-1295. Research protocols frequently pair GHRP-2 with GHRH analogues to examine whether GHS-R1a agonism and GHRH receptor activation produce synergistic effects on growth hormone secretagogue signalling endpoints, a common combination design in pituitary pathway research.
What experimental controls are commonly used in GHRP-2 receptor-signalling research?
Studies investigating GHRP-2 mechanisms typically incorporate vehicle controls, receptor-antagonist controls, and comparator GHS-R1a agonists to distinguish receptor-specific effects from non-specific pathway activation.
Comparative experiments using compounds such as GHRP-6 or Ipamorelin are commonly employed to evaluate differences in signalling selectivity, pathway activation patterns, receptor responsiveness, and downstream transcriptional responses. These approaches help establish mechanistic attribution in GHS-R1a pharmacology research.
